Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma

Gastroenterology

Volumn 149, Issue 5, 2015, Pages 1142-1152.e3

  Reid, Brian J ^a,b   Paulson, Thomas G ^a   Li, Xiaohong ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chromosome Instability; Evolution; Genomics; Overdiagnosis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; ENVIRONMENTAL MUTAGEN; TRANSCRIPTION FACTOR FOXP1; TUMOR MARKER; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PREVENTION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL INSTABILITY; DNA METHYLATION; DNA SEQUENCE; EARLY DIAGNOSIS; ENDOSCOPIC BIOPSY; ESOPHAGEAL ADENOCARCINOMA; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; SINGLE NUCLEOTIDE POLYMORPHISM; TETRAPLOIDY; ADENOCARCINOMA; COMPLICATION; DISEASE COURSE; EARLY CANCER DIAGNOSIS; ENVIRONMENT; ESOPHAGEAL NEOPLASMS; GASTROESOPHAGEAL REFLUX; GENETIC PREDISPOSITION; GENETICS; GENOMICS; MUTATION; PATHOLOGY; PROCEDURES; TRENDS;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; ENVIRONMENT; ESOPHAGEAL NEOPLASMS; GASTROESOPHAGEAL REFLUX; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; MUTATION;

EID: 84943224482     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.07.010     Document Type: Article

References (149)

1. A.K. Rustgi, and H.B. El-Serag Esophageal carcinoma N Engl J Med 371 2014 2499 2509
2. B.J. Reid, X. Li, P.C. Galipeau, and et al. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis Nat Rev Cancer 10 2010 87 101
3. P. Sharma, G.W. Falk, A.P. Weston, and et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus Clin Gastroenterol Hepatol 4 2006 566 572
4. L.A. Anderson, L.J. Murray, S.J. Murphy, and et al. Mortality in Barrett's oesophagus: results from a population based study Gut 52 2003 1081 1084
5. M. Conio, A.J. Cameron, Y. Romero, and et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota Gut 48 2001 304 309
6. M. Hage, P.D. Siersema, H. van Dekken, and et al. Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years Scand J Gastroenterol 39 2004 1175 1179
7. C.E. Macdonald, A.C. Wicks, and R.J. Playford Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study BMJ 321 2000 1252 1255
8. P. Moayyedi, N. Burch, N. Akhtar-Danesh, and et al. Mortality rates in patients with Barrett's oesophagus Aliment Pharmacol Ther 27 2008 316 320
9. M. Solaymani-Dodaran, R.F. Logan, J. West, and et al. Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study Am J Gastroenterol 100 2005 2616 2621
10. F. Hvid-Jensen, L. Pedersen, A.M. Drewes, and et al. Incidence of adenocarcinoma among patients with Barrett's esophagus N Engl J Med 365 2011 1375 1383
11. H.G. Welch, and W.C. Black Overdiagnosis in cancer J Natl Cancer Inst 102 2010 605 613
12. R. Etzioni, N. Urban, S. Ramsey, and et al. The case for early detection Nat Rev Cancer 3 2003 243 252
13. T.L. Vaughan, and R.C. Fitzgerald Precision prevention of oesophageal adenocarcinoma Nat Rev Gastroenterol Hepatol 12 2015 243 248
14. N.R. Barrett Chronic peptic ulcer of the oesophagus and "oesophagitis" Br J Surg 38 1950 175 182
15. P.R. Allison, and A.S. Johnstone The oesophagus lined with gastric mucous membrane Thorax 8 1953 87 101
16. N.R. Barrett The lower esophagus lined by columnar epithelium Surgery 41 1957 881 894
17. B.A.E. Johns Developmental changes in the oesophageal epithelium in man J Anat 86 1952 431 439
18. X. Wang, H. Ouyang, Y. Yamamoto, and et al. Residual embryonic cells as precursors of a Barrett's-like metaplasia Cell 145 2011 1023 1035
19. A.P. Naef, M. Savary, and L. Ozzello Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas J Thorac Cardiovasc Surg 70 1975 826 835
20. W.J. Blot, S.S. Devesa, R.W. Kneller, and et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA 265 1991 1287 1289
21. M.B. Cook, W.H. Chow, and S.S. Devesa Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005 Br J Cancer 101 2009 855 859
22. C. Castro, C. Bosetti, M. Malvezzi, and et al. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015 Ann Oncol 25 2014 283 290
23. S. Kroep, I. Lansdorp-Vogelaar, J.H. Rubenstein, and et al. Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands Am J Gastroenterol 109 2014 336 343 quiz 335, 344
24. R.E. Sampliner Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology Am J Gastroenterol 93 1998 1028 1032
25. J.M. Croswell, D.F. Ransohoff, and B.S. Kramer Principles of cancer screening: lessons from history and study design issues Semin Oncol 37 2010 202 215
26. P. Bytzer, P.B. Christensen, P. Damkier, and et al. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study Am J Gastroenterol 94 1999 86 91
27. P.C. Nowell The clonal evolution of tumor cell populations Science 194 1976 23 28
28. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
29. B. Vogelstein, N. Papadopoulos, V.E. Velculescu, and et al. Cancer genome landscapes Science 339 2013 1546 1558
30. K. Sprouffske, J.W. Pepper, and C.C. Maley Accurate reconstruction of the temporal order of mutations in neoplastic progression Cancer Prev Res (Phila) 4 2011 1135 1144
31. M.T. Barrett, C.A. Sanchez, L.J. Prevo, and et al. Evolution of neoplastic cell lineages in Barrett oesophagus Nat Genet 22 1999 106 109
32. M. Gerlinger, A.J. Rowan, S. Horswell, and et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med 366 2012 883 892
33. E.C. de Bruin, N. McGranahan, R. Mitter, and et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution Science 346 2014 251 256
34. S.C. Baca, D. Prandi, M.S. Lawrence, and et al. Punctuated evolution of prostate cancer genomes Cell 153 2013 666 677
35. P.J. Stephens, C.D. Greenman, B. Fu, and et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development Cell 144 2011 27 40
36. S. Jones, W.D. Chen, G. Parmigiani, and et al. Comparative lesion sequencing provides insights into tumor evolution Proc Natl Acad Sci U S A 105 2008 4283 4288
37. C. Darwin On the Origin of Species 1859 John Murray
38. G. Mendel Versuche über Plflanzen-hybriden Verhandlungen des naturforschenden Ver-eines in Brünn 1865 3 47
39. C.A. Aktipis, V.S. Kwan, K.A. Johnson, and et al. Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research PLoS One 6 2011 e26100
40. M. Greaves, and C.C. Maley Clonal evolution in cancer Nature 481 2012 306 313
41. S.L. Carter, K. Cibulskis, E. Helman, and et al. Absolute quantification of somatic DNA alterations in human cancer Nat Biotechnol 30 2012 413 421
42. C.C. Maley, P.C. Galipeau, J.C. Finley, and et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma Nat Genet 38 2006 468 473
43. X. Li, P.L. Blount, T.L. Vaughan, and et al. Application of biomarkers in cancer risk management: evaluation from stochastic clonal evolutionary and dynamic system optimization points of view PLoS Comput Biol 7 2011 e1001087
44. X. Li, P.C. Galipeau, T.G. Paulson, and et al. Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus Cancer Prev Res (Phila) 7 2014 114 127
45. N. Agrawal, Y. Jiao, C. Bettegowda, and et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma Cancer Discov 2 2012 899 905
46. A.M. Dulak, S.E. Schumacher, J. van Lieshout, and et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis Cancer Res 72 2012 4383 4393
47. A.M. Dulak, P. Stojanov, S. Peng, and et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity Nat Genet 45 2013 478 486
48. K. Nones, N. Waddell, N. Wayte, and et al. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis Nat Commun 5 2014 5224
49. S. Bandla, A. Pennathur, J.D. Luketich, and et al. Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma Ann Thorac Surg 93 2012 1101 1106
50. J. Gu, J.A. Ajani, E.T. Hawk, and et al. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis Cancer Prev Res (Phila) 3 2010 1176 1186
51. T.G. Paulson, C.C. Maley, X. Li, and et al. Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma Clin Cancer Res 15 2009 3305 3314
52. D.J. Nancarrow, H.Y. Handoko, B.M. Smithers, and et al. Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays Cancer Res 68 2008 4163 4172
53. A. Chak, H. Ochs-Balcom, G. Falk, and et al. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction Cancer Epidemiol Biomarkers Prev 15 2006 1668 1673
54. C. Groves, J. Jankowski, F. Barker, and et al. A family history of Barrett's oesophagus: another risk factor? Scand J Gastroenterol 40 2005 1127 1128
55. V. Munitiz, P. Parrilla, A. Ortiz, and et al. High risk of malignancy in familial Barrett's esophagus: presentation of one family J Clin Gastroenterol 42 2008 806 809
56. A.R. Poynton, T.N. Walsh, G. O'Sullivan, and et al. Carcinoma arising in familial Barrett's esophagus Am J Gastroenterol 91 1996 1855 1856
57. Y. Romero, A.J. Cameron, G.R. Locke 3rd, and et al. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma Gastroenterology 113 1997 1449 1456
58. M. Orloff, C. Peterson, X. He, and et al. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma JAMA 306 2011 410 419
59. D.M. Levine, W.E. Ek, R. Zhang, and et al. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus Nat Genet 45 2013 1487 1493
60. C. Palles, L. Chegwidden, X. Li, and et al. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus Gastroenterology 148 2015 367 378
61. Z. Su, L.J. Gay, A. Strange, and et al. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus Nat Genet 44 2012 1131 1136
62. H. Rajagopalan, M.A. Nowak, B. Vogelstein, and et al. The significance of unstable chromosomes in colorectal cancer Nat Rev Cancer 3 2003 695 701
63. T.I. Zack, S.E. Schumacher, S.L. Carter, and et al. Pan-cancer patterns of somatic copy number alteration Nat Genet 45 2013 1134 1140
64. B.J. Reid, R. Kostadinov, and C.C. Maley New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management Clin Cancer Res 17 2011 3512 3519
65. S.J. Leedham, S.L. Preston, S.A. McDonald, and et al. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus Gut 57 2008 1041 1048
66. T.A. Graham, and S.A. McDonald Genetic diversity during the development of Barrett's oesophagus-associated adenocarcinoma: how, when and why? Biochem Soc Trans 38 2010 374 379
67. A.M. Nicholson, T.A. Graham, A. Simpson, and et al. Barrett's metaplasia glands are clonal, contain multiple stem cells and share a common squamous progenitor Gut 61 2012 1380 1389
68. P.S. Rabinovitch, G. Longton, P.L. Blount, and et al. Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables Am J Gastroenterol 96 2001 3071 3083
69. B.J. Reid, D.S. Levine, G. Longton, and et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets Am J Gastroenterol 95 2000 1669 1676
70. M. Robaszkiewicz, E. Hardy, A. Volant, and et al. [Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases] Gastroenterol Clin Biol 15 1991 703 710
71. L. Teodori, W. Gohde, M. Persiani, and et al. DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients Cytometry 34 1998 257 263
72. J.M. Dunn, G.D. Mackenzie, D. Oukrif, and et al. Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy Br J Cancer 102 2010 1608 1617
73. M.B. Fennerty, R.E. Sampliner, D. Way, and et al. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus Gastroenterology 97 1989 815 820
74. A.M. Rygiel, F. Milano, F.J. Ten Kate, and et al. Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens Genes Chromosomes Cancer 47 2008 396 404
75. E.G. Fritcher, S.M. Brankley, B.R. Kipp, and et al. A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus Hum Pathol 39 2008 1128 1135
76. S.H. Doak, G.J. Jenkins, E.M. Parry, and et al. Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus Gut 52 2003 623 628
77. D.L. Persons, W.S. Croughan, K.A. Borelli, and et al. Interphase cytogenetics of esophageal adenocarcinoma and precursor lesions Cancer Genet Cytogenet 106 1998 11 17
78. F. Beuzen, S. Dubois, and J.F. Flejou Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas: a study using in-situ hybridization Histopathology 37 2000 241 249
79. P. Chaves, M. Crespo, C. Ribeiro, and et al. Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved Mod Pathol 20 2007 788 796
80. A.M. Rygiel, F. Milano, F.J. Ten Kate, and et al. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus Cancer Epidemiol Biomarkers Prev 17 2008 1380 1385
81. W. El-Rifai, H.F. Frierson Jr., C.A. Moskaluk, and et al. Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa Gastroenterology 121 2001 592 598
82. C.T. Miller, J.R. Moy, L. Lin, and et al. Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia Clin Cancer Res 9 2003 4819 4825
83. A. Frankel, N. Armour, D. Nancarrow, and et al. Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis Genes Chromosomes Cancer 53 2014 324 338
84. L.A. Lai, T.G. Paulson, X. Li, and et al. Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH Genes Chromosomes Cancer 46 2007 532 542
85. P.H. Riegman, K.J. Vissers, J.C. Alers, and et al. Genomic alterations in malignant transformation of Barrett's esophagus Cancer Res 61 2001 3164 3170
86. D. Michael, D.G. Beer, C.W. Wilke, and et al. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas Oncogene 15 1997 1653 1659
87. S.J. Meltzer, J. Yin, Y. Huang, and et al. Reduction to homozygostiy involving p53 in esophageal cancers demonstrated by the polymerase chain reaction Biochemistry 88 1991 4976 4980
88. L.J. Prevo, C.A. Sanchez, P.C. Galipeau, and et al. p53-mutant clones and field effects in Barrett's esophagus Cancer Res 59 1999 4784 4787
89. B.J. Reid, L.J. Prevo, P.C. Galipeau, and et al. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression Am J Gastroenterol 96 2001 2839 2848
90. P.L. Blount, P.C. Galipeau, C.A. Sanchez, and et al. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy Cancer Res 54 1994 2292 2295
91. K. Dolan, J. Garde, J. Gosney, and et al. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites Br J Cancer 78 1998 950 957
92. M.V. Gonzalez, M.L. Artimez, L. Rodrigo, and et al. Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma J Clin Pathol 50 1997 212 217
93. M.P. Audrezet, M. Robaszkiewicz, B. Mercier, and et al. Molecular analysis of the TP53 gene in Barrett's adenocarcinoma Hum Mutat 7 1996 109 113
94. K. Dolan, S.J. Walker, J. Gosney, and et al. TP53 mutations in malignant and premalignant Barrett's esophagus Dis Esophagus 16 2003 83 89
95. J.H. Moore, E.J. Lesser, D.H. Erdody, and et al. Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma Int J Cancer 56 1994 487 493
96. P.M. Schneider, A.G. Casson, B. Levin, and et al. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases J Thorac Cardiovasc Surg 111 1996 323 331 discussion 331-333
97. F. Muzeau, J.F. Flejou, G. Thomas, and et al. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers Int J Cancer 72 1997 27 30
98. T.G. Paulson, P.C. Galipeau, L. Xu, and et al. p16 mutation spectrum in the premalignant condition Barrett's esophagus PLoS One 3 2008 e3809
99. D.J. Wong, T.G. Paulson, L.J. Prevo, and et al. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium Cancer Res 61 2001 8284 8289
100. P.C. Galipeau, X. Li, P.L. Blount, and et al. NSAIDs modulate CDKN2A, TP53, and DNA content risk for future esophageal adenocarcinoma PLoS Med 4 2007 e67
101. M.M. Streppel, S. Lata, M. DelaBastide, and et al. Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus Oncogene 33 2014 347 357
102. L.B. Alexandrov, S. Nik-Zainal, D.C. Wedge, and et al. Signatures of mutational processes in human cancer Nature 500 2013 415 421
103. K. Wang, S.T. Yuen, J. Xu, and et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer Nat Genet 46 2014 573 582
104. The Cancer Genome Atlas Research N Comprehensive molecular characterization of gastric adenocarcinoma Nature 513 2014 202 209
105. J.M. Weaver, C.S. Ross-Innes, N. Shannon, and et al. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis Nat Genet 46 2014 837 843
106. R. Beroukhim, C.H. Mermel, D. Porter, and et al. The landscape of somatic copy-number alteration across human cancers Nature 463 2010 899 905
107. X.Y. Goh, J.R. Rees, A.L. Paterson, and et al. Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma Gut 60 2011 1317 1326
108. S.E. Shackney, and T.V. Shankey Common patterns of genetic evolution in human solid tumors Cytometry 29 1997 1 27
109. J.C. Finley, B.J. Reid, R.D. Odze, and et al. Chromosomal instability in Barrett's esophagus is related to telomere shortening Cancer Epidemiol Biomarkers Prev 15 2006 1451 1457
110. R.A. Risques, T.L. Vaughan, X. Li, and et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus Cancer Epidemiol Biomarkers Prev 16 2007 2649 2655
111. J. Xing, J.A. Ajani, M. Chen, and et al. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer Cancer Prev Res (Phila Pa) 2 2009 459 465
112. L.A. Lai, R. Kostadinov, M.T. Barrett, and et al. Deletion at fragile sites is a common and early event in Barrett's esophagus Mol Cancer Res 8 2010 1084 1094
113. X. Li, P.C. Galipeau, C.A. Sanchez, and et al. Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression Cancer Prev Res (Phila Pa) 1 2008 413 423
114. M. Greaves Does everyone develop covert cancer? Nat Rev Cancer 14 2014 209 210
115. G. Ciriello, M.L. Miller, B.A. Aksoy, and et al. Emerging landscape of oncogenic signatures across human cancers Nat Genet 45 2013 1127 1133
116. P.C. Galipeau, D.S. Cowan, C.A. Sanchez, and et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus Proc Natl Acad Sci U S A 93 1996 7081 7084
117. S. Lee, M.J. Han, K.S. Lee, and et al. Frequent occurrence of mitochondrial DNA mutations in Barrett's metaplasia without the presence of dysplasia PLoS One 7 2012 e37571
118. F. Miyazono, P.M. Schneider, R. Metzger, and et al. Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett's esophagus Oncogene 21 2002 3780 3783
119. M.T. Suchorolski, T.G. Paulson, C.A. Sanchez, and et al. Warburg and Crabtree effects in premalignant Barrett's esophagus cell lines with active mitochondria PLoS One 8 2013 e56884
120. B.H. Tan, R.J. Skipworth, N.A. Stephens, and et al. Frequency of the mitochondrial DNA 4977bp deletion in oesophageal mucosa during the progression of Barrett's oesophagus Eur J Cancer 45 2009 736 740
121. W.E. Ek, D.M. Levine, M. D'Amato, and et al. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux J Natl Cancer Inst 105 2013 1711 1718
122. A. Chak, A. Faulx, M. Kinnard, and et al. Identification of Barrett's esophagus in relatives by endoscopic screening Am J Gastroenterol 99 2004 2107 2114
123. A.J. Cameron, J. Lagergren, C. Henriksson, and et al. Gastroesophageal reflux disease in monozygotic and dizygotic twins Gastroenterology 122 2002 55 59
124. I. Mohammed, L.F. Cherkas, S.A. Riley, and et al. Genetic influences in gastro-oesophageal reflux disease: a twin study Gut 52 2003 1085 1089
125. H.M. Ochs-Balcom, G. Falk, W.M. Grady, and et al. Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma Transl Res 150 2007 3 17
126. M.F. Buas, D.M. Levine, K.W. Makar, and et al. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma Carcinogenesis 35 2014 2740 2747
127. Y. Berra The Yogi Book 1998 Workman Publishing Company New York
128. S.S. Zeki, R. Haidry, T.A. Graham, and et al. Clonal selection and persistence in dysplastic Barrett's esophagus and intramucosal cancers after failed radiofrequency ablation Am J Gastroenterol 108 2013 1584 1592
129. K.S. Dua, J. Merrill, and R. Komorowski Neosquamous epithelium after ablation of Barrett's epithelium: cause for concern? Gastrointest Endosc 76 2012 1082 1083
130. D. Allende, J. Dumot, and L. Yerian Esophageal squamous cell carcinoma arising after endoscopic ablation therapy of Barrett's esophagus with high-grade dysplasia. Report of a case Dis Esophagus 26 2013 314 318
131. E.C. Gorospe, M. Gupta, G.A. Prasad, and et al. Double trouble: two cases of squamous carcinoma arising from Barrett's dysplasia after endoscopic mucosal resection Am J Gastroenterol 107 2012 1595 1596
132. R.C. Orlando How good is the neosquamous epithelium? Dig Dis 32 2014 164 170
133. J. Cairns Mutation Selection and the Natural History of Cancer Nature 255 1975 197 200
134. A.P. Thrift, N.J. Shaheen, M.D. Gammon, and et al. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study J Natl Cancer Inst 106 2014
135. R. Sager, I.K. Gadi, L. Stephens, and et al. Gene amplification: an example of accelerated evolution in tumorigenic cells Proc Natl Acad Sci U S A 82 1985 7015 7019
136. S. Srivastava, J.W. Gray, B.J. Reid, and et al. Translational Research Working Group developmental pathway for biospecimen-based assessment modalities Clin Cancer Res 14 2008 5672 5677
137. M. Sullivan Pepe, R. Etzioni, Z. Feng, and et al. Phases of biomarker development for early detection of cancer J Natl Cancer Inst 93 2001 1054 1061
138. T.R. Fleming, R.L. Prentice, M.S. Pepe, and et al. Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research Stat Med 13 1994 955 968
139. R.L. Prentice Surrogate endpoints in clinical trials: definition and operational criteria Stat Med 8 1989 431 440
140. E. Montgomery, M.P. Bronner, J.R. Goldblum, and et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation Hum Pathol 32 2001 368 378
141. B.J. Reid, R.C. Haggitt, C.E. Rubin, and et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus Hum Pathol 19 1988 166 178
142. R.D. Odze What the gastroenterologist needs to know about the histology of Barrett's esophagus Curr Opin Gastroenterol 27 2011 389 396
143. T.G. Schnell, S.J. Sontag, G. Chejfec, and et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 120 2001 1607 1619
144. A.P. Weston, P. Sharma, M. Topalovski, and et al. Long-term follow-up of Barrett's high-grade dysplasia Am J Gastroenterol 95 2000 1888 1893
145. P.S. Rabinovitch, B.J. Reid, R.C. Haggitt, and et al. Progression to cancer in Barrett's esophagus is associated with genomic instability Lab Invest 60 1988 65 71
146. M. Quante, G. Bhagat, J.A. Abrams, and et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia Cancer Cell 21 2012 36 51
147. G.R. Ordonez, L.W. Hillier, W.C. Warren, and et al. Loss of genes implicated in gastric function during platypus evolution Genome Biol 9 2008 R81
148. T.R. Fleming, and D.L. DeMets Surrogate end points in clinical trials: are we being misled? Ann Intern Med 125 1996 605 613
149. T.R. Fleming, and J.H. Powers Biomarkers and surrogate endpoints in clinical trials Stat Med 31 2012 2973 2984